Key facts
- This page summarizes Robert G. Shepler's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jun 2023, 18:16.
Robert G. Shepler - 12 Jun 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)
- Reporting relationship
- Director
- Issuer ticker
- AKYA
- Reported as of
- 12 Jun 2023
- Net transaction value
- +$600,000
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2023, 18:16:08 UTC
- Prior SEC filing
- 05 Jun 2023
- Next SEC filing
- 14 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert G. Shepler, by Brian McKelligon, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert G. Shepler filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 12 Jun 2023.
Change
- Previous filing in this sequence was filed on 05 Jun 2023.
- Current net transaction value: +$600,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKYA
transaction
Common Stock
Purchase
- Transaction value
- $600,000
- Shares
- +120,000
- Change %
- +48%
- Price
- $5.00
- Shares after
- 369,592
- Date
- 12 Jun 2023
- Ownership
- Robert G. Shepler Separate Property Trust of 2008
* marks a reported price that did not pass the local price check.